GL Pharm Tech Corp. (KOSDAQ:204840)
924.00
-31.00 (-3.25%)
At close: Jun 1, 2026
GL Pharm Tech Revenue
GL Pharm Tech had revenue of 9.43B KRW in the quarter ending March 31, 2026, with 20.34% growth. This brings the company's revenue in the last twelve months to 36.86B, up 31.40% year-over-year. In the year 2025, GL Pharm Tech had annual revenue of 35.27B with 35.40% growth.
Revenue (ttm)
36.86B
Revenue Growth
+31.40%
P/S Ratio
1.94
Revenue / Employee
1.12B
Employees
33
Market Cap
71.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 35.27B | 9.22B | 35.40% |
| Dec 31, 2024 | 26.05B | 14.93M | 0.06% |
| Dec 31, 2023 | 26.03B | 9.30B | 55.62% |
| Dec 31, 2022 | 16.73B | 4.30B | 34.63% |
| Dec 31, 2021 | 12.43B | 437.53M | 3.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daehan Nupharm | 205.39B |
| Sinsin Pharmaceutical | 118.65B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 108.89B |
| Hwail Pharmaceutical | 107.87B |
| Sinil Pharmaceutical | 82.18B |
| Sam-A Pharm. | 70.93B |
| Polaris AI Pharma | 63.94B |
| Samik Pharmaceutical Company LTD. | 61.48B |